These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9884344)

  • 1. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.
    Fatkin D; Christe ME; Aristizabal O; McConnell BK; Srinivasan S; Schoen FJ; Seidman CE; Turnbull DH; Seidman JG
    J Clin Invest; 1999 Jan; 103(1):147-53. PubMed ID: 9884344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.
    McConnell BK; Jones KA; Fatkin D; Arroyo LH; Lee RT; Aristizabal O; Turnbull DH; Georgakopoulos D; Kass D; Bond M; Niimura H; Schoen FJ; Conner D; Fischman DA; Seidman CE; Seidman JG
    J Clin Invest; 1999 Nov; 104(9):1235-44. PubMed ID: 10545522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy.
    Semsarian C; Healey MJ; Fatkin D; Giewat M; Duffy C; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2001 Nov; 33(11):2055-60. PubMed ID: 11708849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes.
    Kim SJ; Iizuka K; Kelly RA; Geng YJ; Bishop SP; Yang G; Kudej A; McConnell BK; Seidman CE; Seidman JG; Vatner SF
    Am J Physiol; 1999 May; 276(5):H1780-7. PubMed ID: 10330263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.
    Fatkin D; McConnell BK; Mudd JO; Semsarian C; Moskowitz IG; Schoen FJ; Giewat M; Seidman CE; Seidman JG
    J Clin Invest; 2000 Dec; 106(11):1351-9. PubMed ID: 11104788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation.
    Georgakopoulos D; Christe ME; Giewat M; Seidman CM; Seidman JG; Kass DA
    Nat Med; 1999 Mar; 5(3):327-30. PubMed ID: 10086390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C
    Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of familial hypertrophic cardiomyopathy.
    Geisterfer-Lowrance AA; Christe M; Conner DA; Ingwall JS; Schoen FJ; Seidman CE; Seidman JG
    Science; 1996 May; 272(5262):731-4. PubMed ID: 8614836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
    Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
    Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.
    Semsarian C; Ahmad I; Giewat M; Georgakopoulos D; Schmitt JP; McConnell BK; Reiken S; Mende U; Marks AR; Kass DA; Seidman CE; Seidman JG
    J Clin Invest; 2002 Apr; 109(8):1013-20. PubMed ID: 11956238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
    Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
    J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy.
    Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K
    Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in sarcomere protein genes in left ventricular noncompaction.
    Klaassen S; Probst S; Oechslin E; Gerull B; Krings G; Schuler P; Greutmann M; Hürlimann D; Yegitbasi M; Pons L; Gramlich M; Drenckhahn JD; Heuser A; Berger F; Jenni R; Thierfelder L
    Circulation; 2008 Jun; 117(22):2893-901. PubMed ID: 18506004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities.
    Berul CI; Christe ME; Aronovitz MJ; Maguire CT; Seidman CE; Seidman JG; Mendelsohn ME
    J Interv Card Electrophysiol; 1998 Mar; 2(1):7-14. PubMed ID: 9869991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.
    Berul CI; Christe ME; Aronovitz MJ; Seidman CE; Seidman JG; Mendelsohn ME
    J Clin Invest; 1997 Feb; 99(4):570-6. PubMed ID: 9045856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early onset heart failure in transgenic mice with dilated cardiomyopathy.
    Hall DG; Morley GE; Vaidya D; Ard M; Kimball TR; Witt SA; Colbert MC
    Pediatr Res; 2000 Jul; 48(1):36-42. PubMed ID: 10879798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated cardiomyopathy in mice with overexpression of cardiac G(s)alpha and a missense mutation in the alpha-myosin heavy chain.
    Hardt SE; Geng YJ; Montagne O; Asai K; Hong C; Yang GP; Bishop SP; Kim SJ; Vatner DE; Seidman CE; Seidman JG; Homcy CJ; Vatner SF
    Circulation; 2002 Feb; 105(5):614-20. PubMed ID: 11827928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.
    Vikstrom KL; Factor SM; Leinwand LA
    Mol Med; 1996 Sep; 2(5):556-67. PubMed ID: 8898372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.